Innovation Acceleration Center achievements in fighting COVID19

0 May 12 2020 In بین‌المللی توسط بین الملل

COVID19 pandemic has made people from all walks of life try to fight its spread and to get through these critical conditions.

Innovation and technology ecology is also playing its role in this regard.

In line with its social responsibilities and by supporting its accelerators and startups, Innovation Acceleration Center is doing its duty in fighting coronavirus.

 

"Synapse”, "Sivan” and "KARA e-Health Accelerator” are three accelerators that are affiliated with Innovation Acceleration Center and are among those which have been successful in producing two items useful for COVID19 pandemic era.

According to Pardis Technology Park public relations office, "Synapse” as the first accelerator of laboratory diagnostic products has designed and made COVID19 serology test kits.

Mass production of SARS-CoV-2 IgG and SARS-CoV2 IgMkits has been handed over by Vice-President for Science and Technology Sourena Sattari to Pishtaz Teb Zaman Diagnostics and Ideal Tashkhis Atieh Company.

Meanwhile, "Sivan” under the support of the Vice-Presidency for Science and Technology, Health Ministry and Education Ministry presented ‘Safiran Salamati’ application for coronavirus pandemic.

The application provides facilities like training, information dissemination, needs assessment, introducing medical centers, introducing startups and businesses serving people, COVID19 screening tests, special training for students and regional warnings.

 

For more information on installing the application visit www.coronaapp.ir.

"KARA e-Health Accelerator” together with its five startups has presented free services worth 3b rials to startup users and has created jobs for over 400 people.

Doing the COVID19 test without referring to doctor, remote communication services, educational content and controlling health and lifestyle in time of coronavirus were among services which have been presented by "KARA e-Health Accelerator” startups.


Edited On : -/-

No Comments.

Reply